AngioDynamics

AngioDynamics is a leading of medical devices used by interventional radiologists, nephrologists, and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's product line includes market-leading radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.

Company Growth (employees)
Type
Public
HQ
Latham, US
Size (employees)
1,300 (est)
AngioDynamics is headquartered in Latham, US

AngioDynamics Office Locations

AngioDynamics has offices in Latham, Amsterdam-Zuidoost, Oakville, Hong Kong and in 1 other location
Latham, US (HQ)
14 Plaza Dr
Denmead, GB
Falcon Court Forest Rd
Hong Kong, HK
72 Gloucester Rd
Oakville, CA
101 2275 Upper Middle Rd E
Amsterdam-Zuidoost, NL
Margriet Toren 75 Haaksbergweg

AngioDynamics Financials and Metrics

AngioDynamics Financials

AngioDynamics's revenue was reported to be $353.9 m in FY, 2016
USD

Revenue (FY, 2016)

353.9 m

Revenue growth (FY, 2015 - FY, 2016), %

(1%)

Gross profit (FY, 2016)

174.3 m

Gross profit margin (FY, 2016), %

49%

Net income (FY, 2016)

(43.6 m)

EBIT (FY, 2016)

1 m

Market capitalization (19-Oct-2017)

653.1 m

Cash (31-May-2016)

32.3 m

EV

742.2 m
AngioDynamics's current market capitalization is $653.1 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

354.5 m357 m353.9 m

Revenue growth, %

1%(1%)

Cost of goods sold

174.6 m180.1 m179.6 m

Gross profit

179.9 m176.9 m174.3 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

83.7 m89.2 m87.4 m

Cost of goods sold

40.5 m43.4 m43.9 m

Gross profit

43.2 m45.8 m43.5 m

Gross profit Margin, %

52%51%50%
USDFY, 2014FY, 2015FY, 2016

Cash

16.1 m18.4 m32.3 m

Inventories

61.1 m67.4 m55.4 m

Current Assets

152.2 m155.8 m146.3 m

PP&E

67.2 m54.6 m48.3 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

13.8 m14.9 m19.7 m20.3 m19 m21.9 m

Inventories

70.4 m75.3 m68.7 m74.3 m70.8 m65.8 m

Current Assets

154.3 m163.4 m157.3 m160 m151.6 m149.4 m

PP&E

51.2 m49.7 m
USDFY, 2014FY, 2015FY, 2016

Net Income

3.1 m(3.3 m)(43.6 m)

Depreciation and Amortization

16.8 m17.9 m18 m

Accounts Receivable

(15 m)2.1 m3.1 m

Inventories

(5.4 m)(6.2 m)12 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

470 k1.8 m(2.5 m)(757 k)(1.1 m)(489 k)

Depreciation and Amortization

6.7 m14 m22.8 m7.2 m14.4 m21.4 m

Accounts Receivable

5.8 m3.1 m3.5 m5.9 m4.9 m2.5 m

Inventories

(9.2 m)(14.1 m)(7.5 m)(6.9 m)(3.5 m)1.5 m
USDY, 2016

EV/EBIT

729.1 x

EV/CFO

16.4 x

Revenue/Employee

272.2 k

Debt/Equity

0.2 x

Debt/Assets

0.2 x

Financial Leverage

1.4 x
Show all financial metrics

AngioDynamics Market Value History

Traffic Overview of AngioDynamics

AngioDynamics Online and Social Media Presence

AngioDynamics News and Updates

Peripherally Inserted Central Catheters Market will Represent a Value of US$ 1058.6 Mn During 2016-2024

Persistence Market Research has announced the addition of the “Global Market Study on Peripherally Inserted Central Catheters: Power Injected Peripherally Inserted Central Catheters Product Type Segment to Dominate the Market Through 2024" report to their offering. Posted via Industry Today. Follow …

Huber Needles Market will Represent a Value of US$ 55.0 Mn During 2016-2024

Persistence Market Research has announced the addition of the “Global Market Study on Huber Needles: Asia Pacific to Register a Robust CAGR of 8.1% Between 2016 and 2024" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Medical Lasers System Market 2017 Trends, Research, Analysis & Review Forecast 2022

global market for Medical Lasers accounted for $4.94 billion in 2015 and is expected to grow at a CAGR of 14.8% to reach $12.98 billion by 2022. Posted via Industry Today. Follow us on Twitter @IndustryToday

AngioDynamics Company Life and Culture

You may also be interested in